Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82. In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604. Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145. Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396. Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Feb 2020 How Should Physicians in Low- and Middle-Income Countries Regard Electronic Nicotine Delivery Systems to Facilitate Smoking Cessation? Thomas E. Novotny, MD, MPH, DSc (Hon) and May C. I. van Schalkwyk, MBBS, MPH Vaping has been thought to be a safe, effective smoking cessation aid, but little evidence supports its value in mitigating tobacco use. AMA J Ethics. 2020;22(2):E82-92. doi: 10.1001/amajethics.2020.82.
In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145.
Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396.
Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483.
Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495.